Gene & Cell Limited
08983809
Healthy
- Negative net worth (-10)
Details
Compliance
Last accounts
30/04/2025
micro entity
Next accounts due
31/01/2027
Confirmation statement
Last: 03/04/2026
Due 17/04/2027
Industry
Officers
director · Since 08/04/2014
UNIVERSITY ACADEMIC
GREEK · ENGLAND · Age 55
Persons with Significant Control
Dr Panagiotis Takis Athanasopoulos
Greek · England · Age 55
207 Regent Street, 3rd Floor, London, W1B 3HH
Notified 08/04/2016
CompanyRankvs 163800+ SIC 70229 peers33
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/04/2025
Turnover
£0
Annual revenue
Net Worth
£0
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£0
Working capital
Current Assets
£0
Current Liabilities
£0
Fixed Assets
£0
Profit After Tax
£0
Balance Sheet
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2025 | NaN |
| 2025 | NaN |
| 2024 | Infinity |
| 2023 | Infinity |
| 2018 | 0.11 |
Derived from filed accounts. Not audited figures.